Log in
NASDAQ:PDEX

Pro-Dex Stock Forecast, Price & News

$28.77
-0.83 (-2.80 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$28.52
Now: $28.77
$30.39
50-Day Range
$19.01
MA: $24.22
$31.42
52-Week Range
$11.40
Now: $28.77
$32.98
Volume31,962 shs
Average Volume14,923 shs
Market Capitalization$110.42 million
P/E Ratio26.39
Dividend YieldN/A
Beta1.43
Pro-Dex, Inc., together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection molds for various industries; and shavers and machined parts. In addition, it provides engineering, and quality and regulatory consulting services. The company offers its products under the name of Pro-Dex.Pro-Dex, Inc. sells its medical device products primarily to original equipment manufacturers; and dental products to dental product distributors. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PDEX
CUSIPN/A
Phone949-769-3200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$34.83 million
Cash Flow$1.77 per share
Book Value$4.92 per share

Profitability

Net Income$6.11 million

Miscellaneous

Employees80
Market Cap$110.42 million
Next Earnings Date9/24/2020 (Estimated)
OptionableNot Optionable
$28.77
-0.83 (-2.80 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pro-Dex (NASDAQ:PDEX) Frequently Asked Questions

How has Pro-Dex's stock been impacted by COVID-19 (Coronavirus)?

Pro-Dex's stock was trading at $18.24 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PDEX shares have increased by 57.7% and is now trading at $28.77.
View which stocks have been most impacted by COVID-19
.

When is Pro-Dex's next earnings date?

Pro-Dex is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020.
View our earnings forecast for Pro-Dex
.

How were Pro-Dex's earnings last quarter?

Pro-Dex Inc (NASDAQ:PDEX) released its earnings results on Friday, August, 28th. The medical instruments supplier reported $0.63 EPS for the quarter, topping the consensus estimate of $0.18 by $0.45. Pro-Dex had a net margin of 17.55% and a return on equity of 34.17%.
View Pro-Dex's earnings history
.

Who are some of Pro-Dex's key competitors?

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology Group (MRVL) and UnitedHealth Group (UNH).

Who are Pro-Dex's key executives?

Pro-Dex's management team includes the following people:
  • Mr. Richard Lee Van Kirk Jr., CEO, Pres, COO & Director (Age 58)
  • Mrs. Alisha K. Charlton, CFO & Corp. Sec. (Age 49)

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by many different institutional and retail investors. Top institutional shareholders include LSV Asset Management (1.35%) and Globeflex Capital L P (0.82%). Company insiders that own Pro-Dex stock include Alisha Charlton, David Hovda, Kirk Richard Lee Van Jr, Nicholas John Swenson and Raymond E Cabillot.
View institutional ownership trends for Pro-Dex
.

Which major investors are buying Pro-Dex stock?

PDEX stock was acquired by a variety of institutional investors in the last quarter, including Globeflex Capital L P, and LSV Asset Management.
View insider buying and selling activity for Pro-Dex
.

How do I buy shares of Pro-Dex?

Shares of PDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $28.77.

How big of a company is Pro-Dex?

Pro-Dex has a market capitalization of $110.42 million and generates $34.83 million in revenue each year. Pro-Dex employs 80 workers across the globe.

What is Pro-Dex's official website?

The official website for Pro-Dex is www.pro-dex.com.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier can be reached via phone at 949-769-3200 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.